5-mC |
5-methylocytosine |
ACA |
Anti-centromere antibody |
aCL IgG |
Anti Cardiolipin antibody of immunoglobulin G |
aCL IgM |
Anti Cardiolipin antibody of immunoglobulin M |
ACR |
American College of Rheumatology |
ACTDs |
Autoimmune Connective Tissue Diseases |
AMA-M2 |
Anti-mitochondrial M2 antibody-positive autoimmune hepatitis |
ANGPT2 |
Angiopoietin 2 |
Anti-CCP |
anti-cyclic citrullinated peptide autoantibodies |
Anti-CENP-A |
Anti-centromere proteins A |
Anti-CENP-B |
Anti-centromere proteins B |
Anti-dsDNA |
Anti-double stranded DNA |
Anti Jo-1 |
Anti-nuclear antibody |
Anti-La/SSB |
Anti-SLE Sjogren’s syndrome or SLE-related autoantibodies |
Anti-PCNA |
Proliferating cell nuclear antigen antibody |
Anti-Rib-P |
Anti-ribosomal P |
Anti-Ro/SSA |
Anti-Sjogren’s-syndrome-related antigen A autoantibodies |
Anti-Scl-70 |
Anti-topoisomerase I |
Anti-Sm |
Anti-Smith |
Anti-SmB |
Anti-Smith B |
Anti-SmD |
Anti-Smith D |
Anti-U1 RNP |
Anti-U1RNP antibody |
CRP |
C-reactive protein |
DLCO |
Diffusing capacity of the lung of carbon monoxide |
DNMT |
DNA methyltransferase |
DNMT3a |
DNA methyltransferase 3 Alpha |
DNMT3b |
DNA methyltransferase 3 Beta |
dSSc |
diffuse systemic sclerosis |
ESR |
Erythrocyte sedimentation rate |
EULAR |
European Alliance of Associations for Rheumatology |
FCV |
Forced vital capacity |
HDAC4 |
Histone deacetylase 4 |
HRTC |
High-resolution computed tomography |
ILD |
Interstitial lung disease |
LAC |
Lupus anticoagulant antibody |
lSSc |
lLmited systemic sclerosis |
MCTD |
Mixed connective tissue disease |
miRNA |
Micro RNA |
mRSS |
Modified-Rodnan skin score |
MTX |
Methotrexate |
MVEC |
Microvascular endothelial cells |
ncRNA |
Non-coding RNA |
NOS1 |
Nictric oxide synthase 1 |
PBMC |
Peripheral blood mononuclear cell |
RF |
Rheumatoid factor |
SLE |
Systemic lupus erythematosus |
SSc |
Systemic sclerosis |